DOSSIER · 13F Holders · Q4 2025
Biohaven Pharmactl Hldg Co L
1 institutions still hold Biohaven Pharmactl Hldg Co L as of Q4 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP G11196105·1 13F holders·last filed Dec 31, 2025
AI Holders Summary · Q4 2025
1 institutions reported Biohaven Pharmactl Hldg Co L in Q4 2025. Knoll Capital Management, LLC leads at 100.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.